Beyond Air, Inc. (XAIR)
USD 0.24
(-0.49%)
USD 0.24
(-0.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -59.03 Million USD | -1.43% |
| 2023 | -58.2 Million USD | -71.79% |
| 2022 | -42.69 Million USD | -34.63% |
| 2021 | -22.02 Million USD | -22.35% |
| 2020 | -19.84 Million USD | -500.06% |
| 2019 | -6.49 Million USD | 82.32% |
| 2018 | -16.91 Million USD | -401.06% |
| 2017 | -3.38 Million USD | -11448.18% |
| 2016 | -2.18 Million USD | 98.63% |
| 2015 | -2.13 Million USD | -56.03% |
| 2014 | -1.36 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -15.5 Million USD | 29.89% |
| 2024 Q4 | -11.89 Million USD | 17.77% |
| 2024 Q2 | -17.02 Million USD | -10.78% |
| 2024 Q3 | -16.3 Million USD | 1.98% |
| 2024 FY | - USD | -19.19% |
| 2023 Q2 | -12.29 Million USD | -9.81% |
| 2023 Q3 | -13.43 Million USD | -9.26% |
| 2023 Q4 | -13.96 Million USD | -3.96% |
| 2023 FY | - USD | -71.79% |
| 2023 Q1 | -11.19 Million USD | -12.76% |
| 2022 Q4 | -9.93 Million USD | -28.18% |
| 2022 Q2 | -8.36 Million USD | -28.18% |
| 2022 FY | - USD | -34.63% |
| 2022 Q1 | -6.52 Million USD | -31.01% |
| 2022 Q3 | -7.74 Million USD | 7.32% |
| 2021 Q4 | -4.97 Million USD | 10.96% |
| 2021 Q2 | -4.88 Million USD | 25.51% |
| 2021 Q3 | -5.59 Million USD | -14.57% |
| 2021 FY | - USD | -22.35% |
| 2021 Q1 | -6.55 Million USD | 7.0% |
| 2020 Q4 | -7.04 Million USD | -48.75% |
| 2020 FY | - USD | -500.06% |
| 2020 Q3 | -4.73 Million USD | -12.0% |
| 2020 Q2 | -4.22 Million USD | -11.51% |
| 2020 Q1 | -3.79 Million USD | -153.38% |
| 2019 Q1 | -1.74 Million USD | -263.88% |
| 2019 FY | - USD | 82.32% |
| 2019 Q4 | 7.1 Million USD | 223.54% |
| 2019 Q3 | -5.74 Million USD | -139.67% |
| 2019 Q2 | -2.39 Million USD | -37.72% |
| 2018 Q4 | 1.06 Million USD | 112.83% |
| 2018 FY | - USD | -401.06% |
| 2018 Q1 | -3.05 Million USD | 13.98% |
| 2018 Q2 | -2.05 Million USD | 32.88% |
| 2018 Q3 | -8.28 Million USD | -303.65% |
| 2017 Q4 | -3.55 Million USD | -481.67% |
| 2017 FY | - USD | -11448.18% |
| 2017 Q2 | -8684.00 USD | 50.97% |
| 2017 Q1 | -17.71 Thousand USD | -597.24% |
| 2017 Q3 | -611 Thousand USD | -6935.93% |
| 2016 Q2 | -6140.00 USD | 99.18% |
| 2016 FY | - USD | 98.63% |
| 2016 Q4 | -2540.00 USD | 12.32% |
| 2016 Q3 | -2897.00 USD | 52.82% |
| 2016 Q1 | -749.5 Thousand USD | 0.0% |
| 2015 Q4 | -749.5 Thousand USD | -16.38% |
| 2015 Q2 | -644 Thousand USD | -51.89% |
| 2015 Q1 | -424 Thousand USD | 0.0% |
| 2015 FY | - USD | -56.03% |
| 2015 Q3 | -644 Thousand USD | 0.0% |
| 2014 Q4 | -424 Thousand USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -49.77 Million USD | -18.605% |
| BrainsWay Ltd. | -2.31 Million USD | -2454.349% |
| Cerus Corporation | -26.53 Million USD | -122.456% |
| Envoy Medical, Inc. | -18.23 Million USD | -223.67% |
| electroCore, Inc. | -17.76 Million USD | -232.382% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -387.577% |
| IceCure Medical Ltd | -15.25 Million USD | -287.012% |
| Inogen, Inc. | -45.67 Million USD | -29.23% |
| OrthoPediatrics Corp. | -8.38 Million USD | -604.343% |
| Lucid Diagnostics Inc. | -49.75 Million USD | -18.653% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -250.214% |
| MaxCyte, Inc. | -44.12 Million USD | -33.772% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -402.136% |
| Nexalin Technology, Inc. | -5.69 Million USD | -937.079% |
| Orthofix Medical Inc. | -86.98 Million USD | 32.137% |
| PAVmed Inc | -75.74 Million USD | 22.063% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | -9.809% |
| RxSight, Inc. | -41.03 Million USD | -43.848% |
| Sight Sciences, Inc. | -49.41 Million USD | -19.46% |
| SI-BONE, Inc. | -34.44 Million USD | -71.373% |
| TELA Bio, Inc. | -40.63 Million USD | -45.278% |
| Treace Medical Concepts, Inc. | -39 Million USD | -51.33% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -254.009% |
| Acutus Medical, Inc. | -13.48 Million USD | -337.688% |
| Talis Biomedical Corporation | -66.04 Million USD | 10.62% |
| Spectral AI, Inc. | -12.26 Million USD | -381.414% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -23.773% |
| CVRx, Inc. | -38.73 Million USD | -52.413% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1573.214% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -462.495% |
| Bioventus Inc. | -23.07 Million USD | -155.878% |
| Venus Concept Inc. | -26.11 Million USD | -126.06% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | -1.257% |
| LivaNova PLC | 39.01 Million USD | 251.299% |
| 908 Devices Inc. | -34.02 Million USD | -73.493% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 46.623% |
| Nemaura Medical Inc. | -7.28 Million USD | -710.08% |
| NeuroPace, Inc. | -22.83 Million USD | -158.522% |
| LENSAR, Inc. | -8.71 Million USD | -577.427% |
| Apyx Medical Corporation | -18.11 Million USD | -225.922% |
| Cutera, Inc. | -136.56 Million USD | 56.773% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1646.479% |
| BioSig Technologies, Inc. | -28.15 Million USD | -109.694% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 2446.224% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -181.247% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 115.39% |
| Axonics, Inc. | 7.77 Million USD | 859.241% |
| Outset Medical, Inc. | -153.78 Million USD | 61.616% |
| IRIDEX Corporation | -7.44 Million USD | -692.575% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 39.823% |
| IRadimed Corporation | 20.8 Million USD | 383.794% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -632.213% |
| INVO Bioscience, Inc. | -6.88 Million USD | -758.006% |
| Telesis Bio, Inc. | -40.49 Million USD | -45.781% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 260.948% |
| Varex Imaging Corporation | 67.2 Million USD | 187.844% |
| Quipt Home Medical Corp. | 44.07 Million USD | 233.945% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -443.063% |
| Pulmonx Corporation | -55.09 Million USD | -7.15% |
| Dynatronics Corporation | -976 Thousand USD | -5948.209% |
| Modular Medical, Inc. | -17.1 Million USD | -245.15% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -307.532% |
| Semler Scientific, Inc. | 23.58 Million USD | 350.248% |
| InMode Ltd. | 196.28 Million USD | 130.074% |
| Bruker Corporation | 599 Million USD | 109.855% |
| Cytosorbents Corporation | -28.81 Million USD | -104.892% |
| DexCom, Inc. | 916.7 Million USD | 106.44% |
| Align Technology, Inc. | 799.03 Million USD | 107.388% |
| Viveve Medical, Inc. | -20.61 Million USD | -186.322% |
| ZimVie Inc. | 91.07 Million USD | 164.817% |
| Movano Inc. | -29.12 Million USD | -102.682% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -1239.179% |
| Nexalin Technology, Inc. | -5.69 Million USD | -937.079% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1573.214% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 69.674% |
| Profound Medical Corp. | -27.12 Million USD | -117.638% |
| Insulet Corporation | 323.6 Million USD | 118.242% |
| enVVeno Medical Corporation | -25.01 Million USD | -135.954% |
| Surmodics, Inc. | 1.18 Million USD | 5068.939% |
| iCAD, Inc. | -6.56 Million USD | -799.177% |
| Nuwellis, Inc. | -16.35 Million USD | -260.913% |
| Biotricity, Inc. | -8.82 Million USD | -568.659% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 39.057% |
| Aethlon Medical, Inc. | -11.84 Million USD | -398.189% |
| InspireMD, Inc. | -20.91 Million USD | -182.296% |
| PAVmed Inc. | -75.74 Million USD | 22.063% |
| BIOLASE, Inc. | -15.13 Million USD | -289.927% |
| FONAR Corporation | 28.25 Million USD | 308.948% |
| AxoGen, Inc. | -13.32 Million USD | -342.91% |
| Vivani Medical, Inc. | -26.6 Million USD | -121.854% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 340.54% |
| Inari Medical, Inc. | 7.11 Million USD | 929.903% |
| UFP Technologies, Inc. | 72.74 Million USD | 181.15% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1643.495% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -858.919% |
| Tenon Medical, Inc. | -15.52 Million USD | -280.158% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -286.683% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -42.327% |
| AdaptHealth Corp. | -171.09 Million USD | 65.497% |
| Sintx Technologies, Inc. | -6.6 Million USD | -794.409% |
| NanoVibronix, Inc. | -3.43 Million USD | -1618.515% |
| Quanterix Corporation | -38.08 Million USD | -54.986% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -443.063% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 196870.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 78.711% |
| TransMedics Group, Inc. | -7.6 Million USD | -676.417% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -171.22% |
| NeuroMetrix, Inc. | -7.09 Million USD | -731.914% |
| Hyperfine, Inc. | -47.06 Million USD | -25.435% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | -1.242% |
| Biomerica, Inc. | -5.99 Million USD | -884.999% |
| Bone Biologics Corporation | 479.57 Thousand USD | 12409.101% |
| AVITA Medical, Inc. | -39.56 Million USD | -49.19% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -543.535% |
| Silk Road Medical, Inc | -45.08 Million USD | -30.947% |